Market Cap 144.37B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 8.41
Forward PE 8.62
Profit Margin 12.42%
Debt to Equity Ratio 0.71
Volume 37,110,000
Avg Vol 38,161,227
Day's Range N/A - N/A
Shares Out 5.70B
Stochastic %K 6%
Beta 0.35
Analysts Sell
Price Target $29.24

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
trenddetector
trenddetector May. 18 at 3:15 PM
$PFE Behind every prescription for Ibrance, Lorbrena, or Talzenna is a real person trying to understand what comes next. Cancer patients deserve more than a drug name and a pharmacy receipt — they deserve context, clarity, and a path forward. YourCancerPath.com gives them exactly that, for free, anonymously, across 22 cancer types. If someone in your life is navigating breast cancer or lung cancer right now, please share this link with them. It might be the most useful thing you do for them today. 🔗 YourCancerPath.com #breastcancer #lungcancer #PFE #YourCancerPath
0 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 May. 18 at 3:10 PM
$SLS $LLY $PFE CEO Explaining approximately 12,000 AML CR2 patients will be Eligible for GPS Immunotherapy each year EU/US/J. xCCO estimated Minimum Pricing comps of $280K / $300K Rev Per Patient Year 1 Infinite Dosing Regime - Year 2 $110K Rev. - Just AMLCR2/3 is worth Nearly $75 Per Share to Big Pharma and You can't have any CR2/3 Value without Applying further Value for CR1 / Post Stem Cell Transplant, + MESO and PRROC. - GPS +Keytruda Phase 2 PR/ROC MOS of 18.4 Months was better than Elahere $IMGN that got bought for $10.1B ... as a single comp.
0 · Reply
JBS_84
JBS_84 May. 18 at 3:06 PM
$PFE Just timid people confirming the bottom is in. Wait for it
0 · Reply
pasuny
pasuny May. 18 at 2:42 PM
$PFE No hope… miserable…
0 · Reply
nimii
nimii May. 18 at 2:35 PM
$PFE gimme 28
1 · Reply
doubleuptwice
doubleuptwice May. 18 at 2:25 PM
$PFE weird action today hmmm
1 · Reply
pasuny
pasuny May. 18 at 2:09 PM
$PFE the market goes down , this garbage goes down, the market goes up, this garbage goes down. Very very disgusting.
1 · Reply
simonds
simonds May. 18 at 2:09 PM
$PFE Ha Ha
0 · Reply
_Crim_Jamer_
_Crim_Jamer_ May. 18 at 1:53 PM
0 · Reply
pasuny
pasuny May. 18 at 1:49 PM
$PFE stupid disgusting garbage
0 · Reply
Latest News on PFE
Pfizer price target raised to $26 from $25 at Wolfe Research

2026-05-14T17:29:38.000Z - 3 days ago

Pfizer price target raised to $26 from $25 at Wolfe Research


Mixed options sentiment in Pfizer with shares up 0.48%

2026-05-13T19:23:39.000Z - 4 days ago

Mixed options sentiment in Pfizer with shares up 0.48%


Arvinas price target raised to $16 from $14 at BofA

2026-05-13T19:22:15.000Z - 4 days ago

Arvinas price target raised to $16 from $14 at BofA

ARVN RIGL


Mixed options sentiment in Pfizer with shares down 1.52%

2026-05-08T22:49:53.000Z - 9 days ago

Mixed options sentiment in Pfizer with shares down 1.52%


Mixed options sentiment in Pfizer with shares up 0.28%

2026-05-07T01:58:20.000Z - 11 days ago

Mixed options sentiment in Pfizer with shares up 0.28%


Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC

May 5, 2026, 4:09 PM EDT - 12 days ago

Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC


Pfizer CEO on AI-designed molecule, and race to use new tech

May 5, 2026, 4:02 PM EDT - 12 days ago

Pfizer CEO on AI-designed molecule, and race to use new tech


3 Dividend Stocks for May 2026

May 5, 2026, 11:30 AM EDT - 12 days ago

3 Dividend Stocks for May 2026

SYY WSO


Pfizer Earnings Call Transcript: Q1 2026

May 5, 2026, 10:00 AM EDT - 13 days ago

Pfizer Earnings Call Transcript: Q1 2026


Pfizer Posts Better-Than-Expected Revenue, Profit

May 5, 2026, 8:35 AM EDT - 13 days ago

Pfizer Posts Better-Than-Expected Revenue, Profit


Why selling these 3 dividend stocks could be a mistake

May 5, 2026, 7:05 AM EDT - 13 days ago

Why selling these 3 dividend stocks could be a mistake

EPD UPS


US FDA approves Pfizer, Arvinas' breast cancer drug

May 1, 2026, 12:37 PM EDT - 16 days ago

US FDA approves Pfizer, Arvinas' breast cancer drug

ARVN


Pfizer's blood cancer drug meets main goal in late-stage trial

Apr 29, 2026, 7:42 AM EDT - 19 days ago

Pfizer's blood cancer drug meets main goal in late-stage trial


Pfizer Reaches Three Settlement Agreements for VYNDAMAX

Apr 28, 2026, 10:17 AM EDT - 20 days ago

Pfizer Reaches Three Settlement Agreements for VYNDAMAX


Pfizer Transcript: AGM 2026

Apr 23, 2026, 9:00 AM EDT - 25 days ago

Pfizer Transcript: AGM 2026


Pfizer Declares Second-Quarter 2026 Dividend

Apr 22, 2026, 4:45 PM EDT - 25 days ago

Pfizer Declares Second-Quarter 2026 Dividend


Pfizer GLP-1 weight loss drug available for pre-order in China

Apr 22, 2026, 5:18 AM EDT - 26 days ago

Pfizer GLP-1 weight loss drug available for pre-order in China


The Big 3: PFE, V, SYF

Apr 16, 2026, 1:01 PM EDT - 4 weeks ago

The Big 3: PFE, V, SYF

SYF V


Big Pharma Is Turning to China for the Newest Drug Ideas

Apr 10, 2026, 11:00 PM EDT - 5 weeks ago

Big Pharma Is Turning to China for the Newest Drug Ideas


5 ‘Healthy' Dividends Paying Up To 14.1%

Mar 22, 2026, 9:45 AM EDT - 2 months ago

5 ‘Healthy' Dividends Paying Up To 14.1%

ARE BME DOC HQH


China approves Pfizer GLP-1 drug for weight management

Mar 6, 2026, 12:40 AM EST - 2 months ago

China approves Pfizer GLP-1 drug for weight management


trenddetector
trenddetector May. 18 at 3:15 PM
$PFE Behind every prescription for Ibrance, Lorbrena, or Talzenna is a real person trying to understand what comes next. Cancer patients deserve more than a drug name and a pharmacy receipt — they deserve context, clarity, and a path forward. YourCancerPath.com gives them exactly that, for free, anonymously, across 22 cancer types. If someone in your life is navigating breast cancer or lung cancer right now, please share this link with them. It might be the most useful thing you do for them today. 🔗 YourCancerPath.com #breastcancer #lungcancer #PFE #YourCancerPath
0 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 May. 18 at 3:10 PM
$SLS $LLY $PFE CEO Explaining approximately 12,000 AML CR2 patients will be Eligible for GPS Immunotherapy each year EU/US/J. xCCO estimated Minimum Pricing comps of $280K / $300K Rev Per Patient Year 1 Infinite Dosing Regime - Year 2 $110K Rev. - Just AMLCR2/3 is worth Nearly $75 Per Share to Big Pharma and You can't have any CR2/3 Value without Applying further Value for CR1 / Post Stem Cell Transplant, + MESO and PRROC. - GPS +Keytruda Phase 2 PR/ROC MOS of 18.4 Months was better than Elahere $IMGN that got bought for $10.1B ... as a single comp.
0 · Reply
JBS_84
JBS_84 May. 18 at 3:06 PM
$PFE Just timid people confirming the bottom is in. Wait for it
0 · Reply
pasuny
pasuny May. 18 at 2:42 PM
$PFE No hope… miserable…
0 · Reply
nimii
nimii May. 18 at 2:35 PM
$PFE gimme 28
1 · Reply
doubleuptwice
doubleuptwice May. 18 at 2:25 PM
$PFE weird action today hmmm
1 · Reply
pasuny
pasuny May. 18 at 2:09 PM
$PFE the market goes down , this garbage goes down, the market goes up, this garbage goes down. Very very disgusting.
1 · Reply
simonds
simonds May. 18 at 2:09 PM
$PFE Ha Ha
0 · Reply
_Crim_Jamer_
_Crim_Jamer_ May. 18 at 1:53 PM
0 · Reply
pasuny
pasuny May. 18 at 1:49 PM
$PFE stupid disgusting garbage
0 · Reply
Eventsea5
Eventsea5 May. 18 at 1:48 PM
0 · Reply
Micheal_Pothead
Micheal_Pothead May. 18 at 1:39 PM
$PFE dog.
1 · Reply
renoH4
renoH4 May. 18 at 1:33 PM
$PFE ...The specific medication was called TKM-Ebola. It was an RNA interference (RNAi) therapeutic against the Zaire Ebola virus strain prevalent at the time. In animal models, it demonstrated very strong results; in monkeys, it provided complete protection following infection.. Arbutus developed IT.
0 · Reply
Micheal_Pothead
Micheal_Pothead May. 18 at 1:12 PM
$PFE tech going green again, gg us
0 · Reply
Judah731
Judah731 May. 18 at 12:23 PM
$PFE price upgrade
0 · Reply
focafoca99
focafoca99 May. 18 at 12:15 PM
$PFE expects to present new oncology data at ASCO 2026. https://www.rapidticker.com/news/pfe-astellas-to-present-data-on-555864
0 · Reply
Mike22332233
Mike22332233 May. 18 at 12:11 PM
$SLS Some think $40 Bil BO is silly ... really, FOR AN EFFECTIVE CURE FOR CANCER !!! ... and then across 20 other cancers with WT1 !!! Add in the SLS001 platform!!! ... KEYTRUDA has sales of $34 Bil per year and does NOT cure anything ... We will see how silly it is when $MRK, $ABBV and $PFE are in a bidding war to buy out $SLS ... SLS is the Single BEST asymmetrical investment idea in my over 40 years investing ... ALL my profits from every other Special Situation Stock I have found (see my other posts) have been plowed back into more SLS ... If you agree with what I will say, then LIKE this and FOLLOW me 👉 @Mike22332233 ...
0 · Reply
Mike22332233
Mike22332233 May. 18 at 11:55 AM
$SLS PART 2 of 2 .. Even with the BAT arm at 14.7 mOS which is twice as long as expected … EFFECTIVELY, those getting GPS that had an immune response (80% of them) ARE NOT PASSING AWAY!!! ... GAME CHANGING FOR CANCER !!! When the trial ends at the 80th event, I believe you would have ALL 63 in the BAT Control arm passed away, AND ONLY 17 OF THE 63 GPS PATIENTS PASSED AWAY … 46 of the 63 will be alive and living into their 4th yr and some into their 5th year…. This has EFFECTIVELY STOPPED CANCER FROM KILLING THEM IN THIS TYPE OF CANCER !! ... There are an additional 20 or so Cancers with the WT1 within them … as I said before, likely $ABBV or $MEK or $PFE doing a BUY OUT WITHIN 3 months of the readout, and my MAXIMUM PRICE OF $150 to $175 (a $30 to $35 Billion valuation) for the BO may very well be much too low if the HR is GAME-CHANGING at 0.27-0.35 ... if so, expect a bidding war and final BO at $222 !!! ... If you agree then LIKE this and FOLLOW me 👉 @Mike22332233
1 · Reply
renoH4
renoH4 May. 18 at 11:13 AM
$PFE ..If you are looking for a Treatment for EBOLA call Arbutus Biopharm - Last big outbreak 2015 they developed an Experimental formulation. May be together you can find a way to avoid a world catastrovic outbreak.
0 · Reply
Willieberich
Willieberich May. 18 at 11:12 AM
$PFE I'll buy more today and every day for now ..
0 · Reply
YoloAlfred
YoloAlfred May. 18 at 11:10 AM
$PFE are you being a cheap a$$ bull trying to shave a nickel
0 · Reply
pasuny
pasuny May. 18 at 11:05 AM
$PFE miserable pathetic... Stupid garbage selling toxic chemicals to innocent people.
0 · Reply